Theseus Pharmaceuticals Stock

theseusrx.comHealthcareFounded: 2017

Theseus Pharmaceuticals is committed to outsmarting cancer resistance by developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology.

Register for Details

For more details on financing and valuation for Theseus Pharmaceuticals, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Theseus Pharmaceuticals.

Register Today

Other companies like Theseus Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM